[go: up one dir, main page]

AR022084A1 - Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides - Google Patents

Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides

Info

Publication number
AR022084A1
AR022084A1 ARP990104541A ARP990104541A AR022084A1 AR 022084 A1 AR022084 A1 AR 022084A1 AR P990104541 A ARP990104541 A AR P990104541A AR P990104541 A ARP990104541 A AR P990104541A AR 022084 A1 AR022084 A1 AR 022084A1
Authority
AR
Argentina
Prior art keywords
methods
compositions
corticosteroids
otitis
medium
Prior art date
Application number
ARP990104541A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR022084A1 publication Critical patent/AR022084A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente describe composiciones que excluyen antibioticos y métodos para tratar sinusitis y/o otitis media no infecciosas. Las composiciones comprendenuna cantidad terapéuticamente eficaz de un corticosteroide, y los métodos comprendenadministrar una composicion farmacéutica que comprende una cantidadterapéuticamente eficaz de un corticosteroide. Los corticosteroides preferidos son furoato de mometasona y monohidrato de furoato de mometasona.
ARP990104541A 1998-09-10 1999-09-09 Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides AR022084A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15084798A 1998-09-10 1998-09-10

Publications (1)

Publication Number Publication Date
AR022084A1 true AR022084A1 (es) 2002-09-04

Family

ID=22536243

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104541A AR022084A1 (es) 1998-09-10 1999-09-09 Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides

Country Status (8)

Country Link
AR (1) AR022084A1 (es)
AU (1) AU6018999A (es)
CO (1) CO5160268A1 (es)
MY (1) MY133181A (es)
PA (1) PA8481701A1 (es)
PE (1) PE20001051A1 (es)
TW (1) TW589185B (es)
WO (1) WO2000015234A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
ATE418984T1 (de) * 2004-08-13 2009-01-15 Schering Plough Ltd Pharmazeutische formulierungen mit einem antibiotikum, einem triazol und einem kortikosteroid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061729A (en) * 1988-06-08 1991-10-29 Biogal Gyogyszergyar Pharmaceutical composition and process for preparing the same
WO1992004365A1 (en) * 1990-09-10 1992-03-19 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide

Also Published As

Publication number Publication date
PA8481701A1 (es) 2000-09-29
CO5160268A1 (es) 2002-05-30
TW589185B (en) 2004-06-01
PE20001051A1 (es) 2000-10-17
WO2000015234A1 (en) 2000-03-23
AU6018999A (en) 2000-04-03
MY133181A (en) 2007-10-31

Similar Documents

Publication Publication Date Title
RU95113454A (ru) Катехольные диэфиры как селективные ингибиторы фдэiv, фармацевтическая композиция, способы лечения
BR9713186A (pt) Inibidores de metaloprotease 1,3-diheterocìclicos
BR9812753A (pt) Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica
CL2004001170A1 (es) Combinacion farmaceutica inhalable que contiene (a) formoterol, o una sal, o un solvato de el o de la sal y (b) furoato de mometasona; estuche farmaceutico que la comprende; y su uso en la terapia de una enfermedad inflamatoria u obstructiva de las v
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
WO1998056771A3 (en) Piperazine derivatives and their use as anti-inflammatory agents
WO2003068171A3 (en) Method and composition for treatment of inflammation and aids-associated neurological disorders
ES2146300T3 (es) Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos.
ES2154287T3 (es) Procedimiento para modificar el crecimiento de los pelos y/o de los cabellos y composiciones utilizables a este efecto.
NO303816B1 (no) Vandig retinoid-gelblanding
NO20030724D0 (no) Anvendelse av derivater av valproinsyreamider og 2- valproensyreamider for terapi eller prevensjon av smerte- og/eller hodepinelidelser
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
MX163574B (es) Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
RU94031161A (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
BR0308957A (pt) Composto, composição farmacêutica, método para o tratamento de uma inflamação ou de uma desordem associada a uma inflamação em um paciente, uso dos compostos e processo para sua preparação
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
AR022084A1 (es) Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides
BR0315609A (pt) Método de tratar, prevenir, modificar ou controlar dor e composição farmacêutica
BRPI0408113A (pt) métodos para tratar ou prevenir um distúrbio do sistema nervoso central, para controlar um distúrbio do sistema nervoso central e para reduzir ou evitar um efeito adverso associado com a administração de um ingrediente ativo secundário em um paciente que sofre de um distúrbio do sistema nervoso central, e, composição farmacêutica
ECSP993130A (es) Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides (caso alo916)
AR020740A1 (es) Composicion y metodo para tratar enfermedades alergicas

Legal Events

Date Code Title Description
FB Suspension of granting procedure